# hydroxyzine pamoate

NDC: 70934-962
Generic name: hydroxyzine pamoate
Labeler / Manufacturer: Denton Pharma, Inc. DBA Northwind Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20220324
Marketing ended: 20260531
FDA application: ANDA087479

## Active ingredients

- HYDROXYZINE PAMOATE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70934-962"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70934-962
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=db0d9f72-f5b5-48f7-e053-2995a90af2b6